Form 4: UTHR Director Olian Sells $747K Stock via 10b5-1 Plan
Statement of Changes in Beneficial Ownership (Form 4)
United Therapeutics Director Judy D. Olian sold 1,800 shares of common stock for approximately $747,767 through a pre-arranged trading plan.
Summary
- Judy D. Olian, a Director of United Therapeutics Corporation (UTHR), disposed of 1,800 shares of common stock.
- The transaction occurred on September 19, 2025, at a weighted average price of $415.4266 per share.
- The total value of the shares sold was approximately $747,767.88.
- This transaction was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled sale.
- Following this transaction, Judy D. Olian directly beneficially owns 5,045 shares of United Therapeutics Corporation common stock.
Sentiment
Score: 4
Explanation: A director's sale of shares, even if planned under a 10b5-1 program, is generally viewed with slight caution by the market as it reduces insider ownership. However, the pre-arranged nature mitigates concerns about opportunistic selling, leading to a neutral to slightly negative sentiment.
Positives
- The transaction was executed under a Rule 10b5-1 plan, which demonstrates adherence to a pre-arranged trading strategy and enhances transparency regarding insider transactions.
Negatives
- A director's sale of shares, even if planned, reduces their direct beneficial ownership in the company, which some investors might interpret as a slightly negative signal.
Future Outlook
No specific future outlook or guidance was provided in this filing.
Industry Context
This filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders may observe a reduction in direct insider ownership, which could be interpreted in various ways, though the 10b5-1 plan provides context for the transaction.
Key Dates
| Date | Description |
|---|---|
| 09/19/2025 | Date of transaction for the sale of common stock by Director Judy D. Olian. |
Keywords
United Therapeutics, UTHR, Judy D. Olian, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.